Search

Immune Therapy of Multiple Sclerosis - Future Strategies

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4489-4497
Author(s): Sven G. Meuth,Kerstin Gobel,Heinz Wiendl

Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 3191-3201
Author(s): Lara Sanvito, Cris S. Constantinescu, Bruno Gran

Therapeutic Approach to Multiple Sclerosis by Novel Oral Drugs

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 5 Issue: 1 Year: 2011 Page: 66-80
Author(s): Farhad Jadidi-Niaragh, Abbas Mirshafiey

Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis

Journal: Current Neuropharmacology
Volume: 7 Issue: 1 Year: 2009 Page: 60-64
Author(s): D. Moharregh-Khiabani, R. A. Linker, R. Gold, M. Stangel

Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

Journal: Reviews on Recent Clinical Trials
Volume: 5 Issue: 3 Year: 2010 Page: 179-188
Author(s): James J. Marriott, Paul W. OConnor

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 3-15
Author(s): Rainer Ehling, Thomas Berger, Markus Reindl

The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

Journal: Current Neuropharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 256-268
Author(s): Pawel Kawalec,Alicja Mikrut,Natalia Wisniewska,Andrzej Pilc

Multiple Sclerosis: Pathogenesis and Treatment

Journal: Current Neuropharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 409-416
Author(s): Ingrid Loma, Rock Heyman

Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7 Issue: 1 Year: 2007 Page: 35-63
Author(s): C. Kleinschnitz, S. G. Meuth, B. C. Kieseier, H. Wiendl

Pharmacotherapy of Multiple Sclerosis and Treatment Strategies

Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Volume: 9 Year: 2021
Author(s): Amany Ragab,Ali Ibrahim,Rania Helal,Ahmed Elsaid,Hossam Younis,Mona Elsherbiny,Takwa Elkhatib
Doi: 10.2174/9781681089041121090009